Immune-related adverse events: Exploring the side effects of immunotherapy

By SCCA Staff · December 28, 2021

You are invited to a free CME-accredited, provider-focused series of expert-led virtual presentations hosted by SCCA.

In this fourth event, our esteemed speaker Dr. Shruti Gupta presents:

Advances in immunotherapy treatment for renal cancer
Clinical challenges and managing side effects
New and emerging research

A moderated panel discussion follows the didactic presentation. Attendees will have the opportunity to ask questions and discuss cases during a Q&A.

Event details:

January 29, 2022 (9:00-10:30 am PDT)
Topic: Renal immune related adverse events (irAEs)

Guest speaker:

Shruti Gupta, MD, MPH
Director of Onco-Nephrology Research and Associate Physician, Division of Renal Medicine, Brigham and Women’s Hospital/Dana-Farber Cancer Institute
Instructor of Medicine, Harvard Medical School

Co-hosts:

Petros Grivas, MD, PhD
Physician, Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology, University of Washington School of Medicine
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Shailender Bhatia, MD
Director, Melanoma and Renal Cancer Team, Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology, University of Washington School of Medicine
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Immunotherapy A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection and other diseases. A therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection and other diseases. Some immunotherapies only target certain cells of the immune system. Others affect the immune system in a general way. Types of immunotherapy include cytokines, vaccines, bacillus Calmette-Guerin (BCG) and some monoclonal antibodies. Melanoma Cancer that begins in the melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but it can also begin in other pigmented tissues, such as the eye or the intestines.

Subscribe to our e-newsletter

Accreditation:

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each session is 1.0 credit.

If learners claim free CME credit, the value is considered non-monetary compensation and tracked at $25 per learner, which represents Fair Market Value. Any learner can attend for free and choose not to claim free CME credit.

Tags ·

immunotherapy

Back To: Provider Blog